UK to spend more on medicines for US tariff exemptionnews2025-12-01T16:28:20+00:00December 1st, 2025|Endpoints News|
Lilly slightly lowers self-pay prices for single-dose vials of Zepboundnews2025-12-01T14:37:47+00:00December 1st, 2025|Endpoints News|
Novo’s MFN prices to supersede IRA prices for Ozempic, Wegovy, CMS saysnews2025-11-26T19:14:48+00:00November 26th, 2025|Endpoints News|
Lundbeck backs out of bidding war for sleep disorder biotech Avadelnews2025-11-26T18:11:34+00:00November 26th, 2025|Endpoints News|
Novo submits high-dose Wegovy for FDA approval using vouchernews2025-11-26T17:45:45+00:00November 26th, 2025|Endpoints News|
Delayed panel on vaccine injury payments to meet next monthnews2025-11-26T16:44:30+00:00November 26th, 2025|Endpoints News|
FDA pushes back Ascendis’ dwarfism drug decision date by three monthsnews2025-11-26T13:57:06+00:00November 26th, 2025|Endpoints News|
Sanofi headquarters raided in broader French tax fraud investigationnews2025-11-26T11:46:20+00:00November 26th, 2025|Endpoints News|
Otsuka’s anti-APRIL antibody gets FDA approval for kidney disease IgANnews2025-11-26T00:52:17+00:00November 26th, 2025|Endpoints News|
CMS unveils IRA prices for Ozempic, Wegovy and other drugs from second roundnews2025-11-25T23:09:56+00:00November 25th, 2025|Endpoints News|
